当前位置:首页 - 行情中心 - 鸿日达(301285) - 财务分析 - 利润表

鸿日达

(301285)

  

流通市值:23.94亿  总市值:62.85亿
流通股本:7870.98万   总股本:2.07亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入162,248,905.57830,331,289.65644,309,454.81389,498,151.39
营业收入162,248,905.57830,331,289.65644,309,454.81389,498,151.39
二、营业总成本181,395,172.29843,730,705.01628,455,227.6375,797,092.92
营业成本131,515,714.58672,507,775.06488,623,796.72287,046,194.43
税金及附加1,481,031.138,849,847.246,692,682.024,729,631.47
销售费用6,323,270.3125,850,925.5518,495,289.6512,371,136.27
管理费用20,986,596.6170,018,632.7250,989,734.4833,162,040.25
研发费用16,915,813.8558,396,482.2456,080,908.1136,660,659.3
财务费用4,172,745.88,107,042.27,572,816.621,827,431.2
其中:利息费用3,269,590.2415,381,841.5710,525,759.037,236,314.4
其中:利息收入757,053.486,388,721.815,344,047.564,500,753.49
加:公允价值变动收益434,819.43733,236.11243,527.78-137,307.55
加:投资收益1,351,542.24,622,523.744,669,990.662,731,814.37
资产处置收益4,994.49-1,071,432.3139,660.58-
资产减值损失(新)-6,627,520.33-14,757,560.7-1,799,398.78-6,452,524
信用减值损失(新)1,618,489.84-3,978,954.98-3,599,144.57-3,331,950.33
其他收益1,190,605.649,660,085.848,673,704.815,545,495.93
营业利润平衡项目0000
四、营业利润-21,173,335.45-18,191,517.6524,182,567.6912,056,586.89
加:营业外收入5,184,442.3629,811.760.7345.09
减:营业外支出30,000459,345.89185,279.09183,444.9
利润总额平衡项目0000
五、利润总额-16,018,893.09-18,621,051.7823,997,289.3311,873,187.08
减:所得税费用-3,719,510.05-10,983,096.41-5,510,655.83-4,201,366.44
六、净利润-12,299,383.04-7,637,955.3729,507,945.1616,074,553.52
持续经营净利润--7,637,955.3729,507,945.1616,074,553.52
归属于母公司股东的净利润-12,170,909.33-7,572,834.829,567,068.5616,077,354.62
少数股东损益-128,473.71-65,120.57-59,123.4-2,801.1
(一)基本每股收益-0.06-0.040.140.08
(二)稀释每股收益-0.06-0.040.140.08
八、其他综合收益1,988,941.38-507,415.03-1,250,389.92-1,192,867.36
归属于母公司股东的其他综合收益1,988,941.38-507,415.03-1,250,389.92-1,192,867.36
九、综合收益总额-10,310,441.66-8,145,370.428,257,555.2414,881,686.16
归属于母公司股东的综合收益总额-10,181,967.95-8,080,249.8328,316,678.6414,884,487.26
归属于少数股东的综合收益总额-128,473.71-65,120.57-59,123.4-2,801.1
公告日期2025-04-242025-04-242024-10-302024-08-10
审计意见(境内)标准无保留意见
TOP↑